Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer R Cochran

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Biotechnology and Bioengineering|June 3, 2017
A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular functionAmanda N Steele, Lei Cai, Vi N Truong, et al.
The Journal of Clinical Investigation|November 29, 2016
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapiesMihalis S Kariolis, Yu Rebecca Miao, Anh Diep, et al.
Nature Biotechnology|January 22, 2003
Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display libraryMichael J Feldhaus, Robert W Siegel, Lee K Opresko, et al.
Oncoimmunology|December 7, 2017
CAR T-cell immunotherapy of MET-expressing malignant mesotheliomaThivyan Thayaparan, Roseanna M Petrovic, Daniela Y Achkova, et al.
Biomaterials|February 10, 2015
Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarctionSonya B Sonnenberg, Aboli A Rane, Cassie J Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2024
Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and functionJohn L Silberstein, Jasper Du, Kun-Wei Chan, et al.
Nature Medicine|November 9, 2019
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinomaJun W Kim, Cesar P Marquez, Kaja Kostyrko, et al.
The Journal of Experimental Medicine|May 6, 2017
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responsesByron H Kwan, Eric F Zhu, Alice Tzeng, et al.
Science Advances|April 8, 2022
Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumorsAbigail K Grosskopf, Louai Labanieh, Dorota D Klysz, et al.
The Journal of Biological Chemistry|April 13, 2004
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptorTerrance G Johns, Timothy E Adams, Jennifer R Cochran, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Biotechnology and Bioengineering|June 3, 2017
A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular functionAmanda N Steele, Lei Cai, Vi N Truong, et al.
The Journal of Clinical Investigation|November 29, 2016
Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapiesMihalis S Kariolis, Yu Rebecca Miao, Anh Diep, et al.
Nature Biotechnology|January 22, 2003
Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display libraryMichael J Feldhaus, Robert W Siegel, Lee K Opresko, et al.
Oncoimmunology|December 7, 2017
CAR T-cell immunotherapy of MET-expressing malignant mesotheliomaThivyan Thayaparan, Roseanna M Petrovic, Daniela Y Achkova, et al.
Biomaterials|February 10, 2015
Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarctionSonya B Sonnenberg, Aboli A Rane, Cassie J Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 14, 2024
Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and functionJohn L Silberstein, Jasper Du, Kun-Wei Chan, et al.
Nature Medicine|November 9, 2019
Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinomaJun W Kim, Cesar P Marquez, Kaja Kostyrko, et al.
The Journal of Experimental Medicine|May 6, 2017
Integrin-targeted cancer immunotherapy elicits protective adaptive immune responsesByron H Kwan, Eric F Zhu, Alice Tzeng, et al.
Science Advances|April 8, 2022
Delivery of CAR-T cells in a transient injectable stimulatory hydrogel niche improves treatment of solid tumorsAbigail K Grosskopf, Louai Labanieh, Dorota D Klysz, et al.
The Journal of Biological Chemistry|April 13, 2004
Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptorTerrance G Johns, Timothy E Adams, Jennifer R Cochran, et al.
Pageof 11